Contact Congress about H.R. 3082: Evidence-Based Drug Policy Act of 2025

Right now, federal law orders the White House drug czar to oppose any legalization of Schedule I substances and blocks funding for research into it. This bill repeals that mandate so drug policy can be guided by evidence instead of a blanket prohibition on even studying the question.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Evidence-Based Drug Policy Act of 2025 is a House bill in committee. The latest recorded action: Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 3082: Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill primarily affects the White House drug policy office and the researchers, agencies, and communities connected to federal drug strategy. It could also indirectly affect states that have changed their own drug laws and face tension with federal policy.

Why this matters: Federal drug policy has operated under a mandate to oppose legalization since 1998, regardless of what science and public health data show. This bill asks whether it still makes sense to legally require the government's top drug policy office to take a predetermined position. Removing the mandate does not change any drug's legal status, but it opens the door for federal policy to evolve based on evidence.

Key provisions in H.R. 3082

• The bill is titled the "Evidence-Based Drug Policy Act of 2025."
• It repeals section 704(b)(12) of the ONDCP Reauthorization Act of 1998 (21 U.S.C. 1703(b)(12)), which required the Director to oppose legalization of Schedule I drugs and banned funding for legalization research.
• The repealed provision is part of the statute defining the duties of the Office of National Drug Control Policy.
• The bill does not create new programs, funding, or enforcement tools — it only removes one existing mandate.
• The bill was referred to the House Committees on Oversight and Government Reform, Energy and Commerce, and the Judiciary.

How Modern Action helps you take action on H.R. 3082

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 3082

What is H.R. 3082?

Right now, federal law orders the White House drug czar to oppose any legalization of Schedule I substances and blocks funding for research into it. This bill repeals that mandate so drug policy can be guided by evidence instead of a blanket prohibition on even studying the question.

How do I support or oppose H.R. 3082?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 3082?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 3082 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.